Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.02
Delayed Data
As of 4:00pm ET
 -0.28 / -3.37%
Today’s Change
7.81
Today|||52-Week Range
19.43
-48.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues39.5M19.4M36.6M84.5M
 
 
 
 
 
Depreciation And Amortization988.0K997.0K1.5M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses85.3M91.0M91.4M157.1M
 
 
 
 
 
Research And Development67.1M65.6M65.7M114.9M
 
 
 
 
 
Total Operating Expenses86.3M91.9M92.9M159.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.8M-72.6M-56.4M-75.1M
 
 
 
 
 
Extraordinary Credit1.8M0.000.000.00
 
 
Extraordinary Charge-1.9M0.000.00-2.1M
 
 
 
Other Expenses431.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.4M-71.7M-54.6M-68.9M
 
 
 
 
 
Income Taxes-5.7M-14.0K0.000.00
 
 
 
Minority Interest0.000.000.00-555.0K
 
 
Net Income-40.7M-71.7M-54.6M-68.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.8M70.6M78.1M96.9M
 
 
 
 
 
Shares To Calculate EPS Diluted69.8M70.6M78.1M96.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.58-$1.02-$0.70-$0.70
 
 
 
 
 
EPS Diluted-$0.58-$1.02-$0.70-$0.70